EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Upregulated CircRNAs With Efficacy in Preclinical In Vivo Models Reveal New Targets for Therapeutic Intervention in Glioma

Satu Nahkuri, Ulrich H Weidle

Cancer Genomics - Proteomics · 2026-07 · 23 (4) · 588-616

DOI: 10.21873/cgp.20591 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Genomics - Proteomics, online erschienen am 29.06.2026. Verfasst von Satu Nahkuri und 1 weiteren Autor:innen. Beteiligte Einrichtung: Roche Innovation Center Zurich, Roche Glycart AG, Schlieren, Switzerland; satu.nahkuri@roche.com. Hauptthemen laut MEDLINE: Glioma, RNA, Circular, Brain Neoplasms. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There is a significant need to improve treatment efficacy for patients with glioma. Therefore, we have analyzed the literature for the role of circular RNAs (circRNAs) with respect to selected pathology-related topics of glioma. We have focused on upregulated circRNAs with efficacy in preclinical in vivo models. The identified circRNAs cover the following topics: Temozolomide (TMZ) resistance, transmembrane and secreted proteins, wingless-related integration site (WNT) signaling, cytoskeleton dynamics, cell-cell and cell-extracellular matrix interactions, as well as circRNAs with additional functions. We describe possible therapeutic tools and challenges with respect to delivery of the corresponding inhibitory agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GliomaRNA, CircularBrain NeoplasmsHumansAnimalsUp-RegulationGene Expression Regulation, NeoplasticTemozolomide

Stichwörter der Autor:innen

Micro-tubespathway modulationreviewsiRNAsmall-interfering RNAtarget validationtumor-nerve synapsesxenograft models

Substanzen

RNA, CircularTemozolomide

Autor:innen und Institutionen

  • Roche Innovation Center Zurich, Roche Glycart AG, Schlieren, Switzerland; satu.nahkuri@roche.com.
  • Roche Pharma Research and Early Development, Roche Innovation Center Munich, Penzberg, Germany.

Zitieren

APA

Nahkuri, S., & Weidle, U. H. (2026). Upregulated CircRNAs With Efficacy in Preclinical In Vivo Models Reveal New Targets for Therapeutic Intervention in Glioma. Cancer Genomics - Proteomics, 23(4), 588-616. https://doi.org/10.21873/cgp.20591

Vancouver

Nahkuri S, Weidle UH. Upregulated CircRNAs With Efficacy in Preclinical In Vivo Models Reveal New Targets for Therapeutic Intervention in Glioma. Cancer Genomics - Proteomics. 2026;23(4):588-616. doi:10.21873/cgp.20591

BibTeX
@article{Nahkuri2026,
  author = {Nahkuri, Satu and Weidle, Ulrich H},
  title = {Upregulated CircRNAs With Efficacy in Preclinical In Vivo Models Reveal New Targets for Therapeutic Intervention in Glioma},
  journal = {Cancer Genomics - Proteomics},
  year = {2026},
  volume = {23},
  number = {4},
  pages = {588--616},
  doi = {10.21873/cgp.20591}
}
Kostenlos starten →